Chemotherapeutic Management of Stage IV Non-small Cell Lung Cancer*

This publication has 69 references indexed in Scilit:

• Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial
  The Lancet, 2001
• Adenocarcinoma of the lung in young patients
  Cancer, 2000
• Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial
  European Journal Of Cancer, 1998
• Symptomatic benefit from gemcitabine and other chemotherapy in advanced non-small cell lung cancer: changes in performance status and tumour-related symptoms
  Anti-Cancer Drugs, 1995
• Cisplatin-Cyclophosphamide-Mitomycin Combination Chemotherapy With Supportive Care Versus Supportive Care Alone for Treatment of Metastatic Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1993
• Chemotherapy of non-small cell lung cancer according to disease extent: a meta-analysis of the literature
  Lung Cancer, 1991
• Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.
  BMJ, 1990
• Continuation of chemotherapy versus supportive care alone in patients with inoperable non-small cell lung cancer and stable disease after two or three cycles of MACC. Results of a randomized prospective study
  Cancer, 1989
• Quality of Life During Chemotherapy in Non-Small Cell Lung Cancer Patients
  Acta Oncologica, 1989
• Survival with inoperable lung cancer.An integration of prognostic variables based on simple clinical criteria
  Cancer, 1977